Safety of AMP-101 (AAV.Dok7) in Non-Human Primates

被引：0
|
作者：
Sepulveda, Patricio [1 ]
机构：
[1] Amplo Biotechnol, La Jolla, CA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1389
引用
收藏
页码：658 / 659
页数：2
相关论文
共 50 条
  • [41] Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
    van Meer, Peter J. K.
    Kooijman, Marlous
    Brinks, Vera
    Gispen-de Wied, Christine C.
    Silva-Lima, Beatriz
    Moors, Ellen H. M.
    Schellekens, Huub
    MABS, 2013, 5 (05) : 810 - 816
  • [42] Comparable efficiency of photoreceptor transduction by AAV2tYF, AAV5 and AAV8 in non-human primates
    Shearman, M. S.
    Song, C. J.
    Ye, G.
    Timmers, A. M.
    Newmark, J.
    HUMAN GENE THERAPY, 2018, 29 (12) : A153 - A153
  • [43] Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates
    Burdo, Tricia H.
    Chen, Chen
    Kaminski, Rafal
    Sariyer, Ilker K.
    Mancuso, Pietro
    Donadoni, Martina
    Smith, Mandy D.
    Sariyer, Rahsan
    Caocci, Maurizio
    Liao, Shuren
    Liu, Hong
    Huo, Wenwen
    Zhao, Huaqing
    Misamore, John
    Lewis, Mark G.
    Simonyan, Vahan
    Xu, Ethan Y.
    Cradick, Thomas J.
    Gordon, Jennifer
    Khalili, Kamel
    GENE THERAPY, 2024, 31 (5-6) : 224 - 233
  • [44] The safety assessment and the pharmacodynamics evaluation of therapeutic cytokine in non-human primates
    Li, Wei
    Xu, Yixuan
    Zhou, Xin
    Zhu, Dan
    Xiao, Meng
    Zhou, Yulin
    Yang, Zhijie
    Li, Haodong
    Pang, Bo
    Song, Xinghai
    Xiao, Yan
    Shi, Wenting
    Qian, Qian
    Gu, Qingyang
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates
    Tricia H. Burdo
    Chen Chen
    Rafal Kaminski
    Ilker K. Sariyer
    Pietro Mancuso
    Martina Donadoni
    Mandy D. Smith
    Rahsan Sariyer
    Maurizio Caocci
    Shuren Liao
    Hong Liu
    Wenwen Huo
    Huaqing Zhao
    John Misamore
    Mark G. Lewis
    Vahan Simonyan
    Elaine E. Thompson
    Ethan Y. Xu
    Thomas J. Cradick
    Jennifer Gordon
    Kamel Khalili
    Gene Therapy, 2024, 31 : 224 - 233
  • [46] Effect of neutralizing anti-AAV antibodies on vector transduction following intravitreal administration of AAV in non-human primates
    Turunen, H. T.
    Timmers, A.
    Newmark, J.
    Pennock, S.
    Shearman, M. S.
    HUMAN GENE THERAPY, 2018, 29 (12) : A85 - A85
  • [47] Neutralizing anti-AAV antibody impact on vector transduction following intravitreal administration of AAV in non-human primates
    Shearman, M. S.
    Turunen, H. T.
    Newmark, J.
    Pennock, S.
    Timmers, A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A115 - A116
  • [48] Effect of Neutralizing Anti-AAV Antibodies on Vector Transduction Following Intravitreal Administration of AAV in Non-Human Primates
    Turunen, Heikki
    Timmers, Adrian M.
    Newmark, Judith
    Pennock, Steven
    Shearman, Mark S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [49] Preclinical Study of AAV-Mediated SOD1 Knockdown in Non-Human Primates
    Borel, Florie
    Brown, Robert
    Mueller, Chris
    MOLECULAR THERAPY, 2014, 22 : S101 - S101
  • [50] Intravenous aav injection targets the enteric nervous system in guinea pigs and non-human primates
    Gombash, S. E.
    Cowley, C. J.
    Fitzgerald, J. A.
    Lepak, C. A.
    Hook, K.
    Armstrong, E.
    Kaspar, B. K.
    Todd, L.
    Fischer, A. J.
    Bielefeld, E. C.
    Foust, K. D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 88 - 88
12345